• AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts

    Источник: Buzz FX / 17 ноя 2024 00:31:19   America/Chicago


    AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 17, 2024 Share Link copied to clipboard. Shares of AnaptysBio, Inc. ( NASDAQ:ANAB - Get Free Report ) have earned a consensus
    Read more...
Опубликовать